Analyst Consensus ?
ConsensusHold29 ratings
Bullish1551.7%
Neutral1344.8%
Bearish13.5%
Tyson Foods, Inc. · TSN · FY2024 Q4 · Calendar Q4 2024
Tyson posts strongest results in eight quarters; beef remains the risk
The call supports a recovery thesis for Tyson: chicken, prepared foods and pork improved, while operational execution and capital discipline remain central. The counterweight is continued beef-cycle pressure and sensitivity to supply, feed costs and consumer demand.
Reported Before market openNYSEConsumer Defensive
$19.84B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $0.69
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $13.43B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+6.5%
Event window
SPY move
-0.3%
Same window
Abnormal move
+6.9%
Stock minus SPY
Volume
3.7×
Versus trailing sessions
Subsequent drift
-1.2%
Up to 20 sessions
TSNSPY benchmark
Ask FN2 about TSN FY2024 Q4
Transcript, numbers and history already loaded
What drove TSN's +6.5% move after FY2024 Q4 earnings?What changed in TSN's guidance and outlook in FY2024 Q4?Give me the bull and bear case for TSN after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management characterized the fourth quarter and full year as Tyson's strongest in eight quarters, with adjusted operating income more than doubling year over year and adjusted EPS up 130%. FY2025 guidance was maintained, with prepared foods and chicken expected to provide the main AOI contribution.
Guidance delta
Maintained. FY2025 adjusted operating income guidance is $1.8-$2.2 billion, according to the supplied call analysis.
Key takeaways
- Chicken, prepared foods and pork drove the reported improvement, while beef margins remained compressed by the cattle cycle.
- Management emphasized operational excellence, digital analytics and value-added brands as multi-year execution pillars.
- The Danville fully-cooked plant was described as sold out in its first year, with a second facility planned.
- Free cash flow exceeded $1.5 billion, and management highlighted continued balance-sheet discipline.
Management priorities
- Expand value-added chicken and branded products, including Jimmy Dean and Hillshire Farm.
- Advance the Danville fully-cooked facility expansion and related product rollout.
- Use digitalization and analytics to improve yield, mix and supply-chain efficiency.
- Maintain disciplined capital allocation and target net leverage at or below 2x EBITDA.
Follow TSN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$56.4Previous close
$35Low
$62.9Average
$99High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Oct 7, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Sep 18, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Sep 4, 2026 |
| Barclays | Overweight | Overweight | Maintain | Sep 4, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jul 2, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 2, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | May 5, 2026 |
| Mizuho | Outperform | Buy | Maintain | Mar 26, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| HSBC | Reduce | Reduce | Maintain | May 7, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 17, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 7, 2023 |
| Argus Research | Hold | Buy | Downgrade | Sep 13, 2022 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 20, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 13, 2019 |
| Argus | Buy | Hold | Upgrade | May 14, 2019 |
| Vertical Research | Buy | Hold | Upgrade | Jan 10, 2019 |
| Vertical Group | Buy | Hold | Upgrade | Jan 10, 2019 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 8, 2018 |
| Pivotal Research | Hold | Sell | Upgrade | Nov 13, 2017 |
| Jefferies | Buy | Buy | Maintain | Oct 30, 2017 |
| CLSA | Buy | Outperform | Maintain | Oct 10, 2016 |
| BB&T Capital | Hold | Buy | Downgrade | Mar 4, 2016 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Jan 5, 2016 |
| Cleveland Research | Buy | Neutral | Upgrade | Feb 5, 2015 |
| Keybanc | Buy | Buy | Maintain | Jul 29, 2014 |
| DA Davidson | Buy | Buy | Maintain | Jul 10, 2013 |
| Miller Tabak | Buy | Neutral | Upgrade | May 7, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $56.4. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $56 | $51.97 | -0.7% | Oct 7, 2026 |
| Piper Sandler | Analyst unavailable | $66 | $51.74 | +17.0% | Sep 10, 2026 |
| Barclays | Analyst unavailable | $75 | $51.76 | +33.0% | Sep 4, 2026 |
| BMO Capital | Andrew Strelzik | $65 | $51.76 | +15.2% | Sep 4, 2026 |
| Bernstein | Alexia Howard | $66 | $58.12 | +17.0% | Aug 4, 2026 |
| Coker Palmer | Thomas Palmer | $65 | $57.48 | +15.2% | Jul 14, 2026 |
| Bernstein | Analyst unavailable | $63 | $58.43 | +11.7% | Jul 2, 2026 |
| Piper Sandler | Michael Lavery | $78 | $56.2 | +38.3% | Jun 18, 2026 |
| Piper Sandler | Analyst unavailable | $80 | $68.76 | +41.8% | May 4, 2026 |
| Bernstein | Analyst unavailable | $69 | $65.74 | +22.3% | Feb 3, 2026 |
| BMO Capital | Andrew Strelzik | $73 | $65.74 | +29.4% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $78 | $65.74 | +38.3% | Feb 3, 2026 |
| BMO Capital | Analyst unavailable | $67 | $56.2 | +18.8% | Jan 8, 2026 |
| Piper Sandler | Michael Lavery | $61 | $59.56 | +8.2% | Dec 12, 2025 |
| Stephens | Pooran Sharma | $61 | $55.75 | +8.2% | May 6, 2025 |
| Coker Palmer | Thomas Palmer | $60 | $60.54 | +6.4% | Apr 15, 2025 |
| Piper Sandler | Michael Lavery | $58 | $61.69 | +2.8% | Nov 13, 2024 |
| BMO Capital | Andrew Strelzik | $62 | $61.69 | +9.9% | Nov 13, 2024 |
| Barclays | Benjamin Theuer | $76 | $62.66 | +34.8% | Nov 12, 2024 |
| Bank of America Securities | Peter Galbo | $62 | $59.85 | +9.9% | Oct 15, 2024 |
| Piper Sandler | Michael Lavery | $50 | $60.52 | -11.3% | Sep 25, 2024 |
| Barclays | Benjamin Theuer | $72 | $65.13 | +27.7% | Sep 5, 2024 |
| BMO Capital | Andrew Strelzik | $60 | $62.08 | +6.4% | Aug 6, 2024 |
| Coker Palmer | Thomas Palmer | $63 | $62.51 | +11.7% | Aug 5, 2024 |
| Piper Sandler | Michael Lavery | $57 | $58.33 | +1.1% | May 7, 2024 |
| BMO Capital | Andrew Strelzik | $58 | $58.28 | +2.8% | May 7, 2024 |
| Barclays | Benjamin Theuer | $69 | $58.12 | +22.3% | Apr 16, 2024 |
| Coker Palmer | Thomas Palmer | $62 | $57.6 | +9.9% | Apr 3, 2024 |
| Loop Capital Markets | Andrew Strelzik | $46 | $47.77 | -18.4% | Nov 14, 2023 |
| Stephens | Ben Bienvenu | $70 | $47.58 | +24.1% | Nov 14, 2023 |
| Barclays | Benjamin Theurer | $50 | $46.39 | -11.3% | Nov 10, 2023 |
| UBS | Kevin Caliendo | $37 | $52.66 | -34.4% | Jul 24, 2023 |
| Deutsche Bank | Steve Powers | $35 | $50.39 | -37.9% | May 19, 2023 |
| Bernstein | Alexia Howard | $48 | $48.95 | -14.9% | May 9, 2023 |
| J.P. Morgan | Analyst unavailable | $63 | $59.92 | +11.7% | Feb 7, 2023 |
| Credit Suisse | Analyst unavailable | $58 | $61.08 | +2.8% | Feb 7, 2023 |
| Goldman Sachs | Analyst unavailable | $66 | $61.08 | +17.0% | Feb 7, 2023 |
| Piper Sandler | Analyst unavailable | $65 | $65.75 | +15.2% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $58 | $67.33 | +2.8% | Nov 28, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $64.34 | +24.1% | Nov 15, 2022 |
| BMO Capital | Analyst unavailable | $75 | $64.83 | +33.0% | Nov 15, 2022 |
| Piper Sandler | Michael Lavery | $79 | $79.92 | +40.1% | Aug 9, 2022 |
| Piper Sandler | Michael Lavery | $85 | $92.84 | +50.7% | May 10, 2022 |
| Piper Sandler | Michael Lavery | $81 | $90.1 | +43.6% | May 3, 2022 |
| BMO Capital | Kenneth Zaslow | $99 | $87.14 | +75.5% | Mar 18, 2022 |
Track every rating change on TSN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTyson Foods, Inc. operates as a prominent global food producer, encompassing a broad range of activities across four core divisions: Beef, Pork, Chicken, and Prepared Foods. Within its Beef and Pork segments, the company manages the entire process from live cattle and hogs to their transformation into various meat products. This includes fabricating whole carcasses into primary and secondary cuts, providing case-ready options, and producing fully cooked meats. Its Chicken division is responsible for raising and processing poultry, delivering a spectrum of fresh, frozen, and value-added chicken items, and also supplying breeding stock. Additionally, Tyson markets specialty by-products such as animal hides. The Prepared Foods unit focuses on manufacturing and distributing a diverse portfolio of frozen and refrigerated convenience foods.…
Historical context
All TSN earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| KOF Coca-Cola FEMSA, S.A.B. de C.V. | FY2026 Q3 · Calendar Q4 2026 | -9.0% | -1.9% | KOF: Record volume growth meets cost and capacity pressure |
| PG The Procter & Gamble Company | FY2027 Q1 · Calendar Q4 2026 | +6.4% | +5.6% | P&G: Volume Growth Supports FY2027 Guidance Despite Cost Headwinds |
Latest beats and misses
Who reports nextBeat on EPS
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
- BAHFY2027 Q2 · October 23, 2026+18.9% EPS-0.3% move
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
Missed on EPS
- KOFFY2026 Q3 · October 26, 2026-9.0% EPS-1.9% move
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
Get the TSN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:39:04.055137+00:00
- Polygon adjusted daily market bars · 2026-10-27T08:50:44.501914+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T08:50:44.499149+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.